about ispe

Board of Directors

Board members can access materials for upcoming board meetings by clicking here. (Special Board member login required.)

Class of 2023

Tomoko Kobayashi

Tomoko Kobayashi
Epidemiologist, Real World Evidence, Science & Data Analytics Division, Research & Development, Astrazeneca K.K.
Osaka, Japan
Serving first 3-year term

Mette Nørgaard

Mette Nørgaard
Professor in Epidemiology of Urinary Tract Diseases, Department of Clinical Epidemiology
Aarhus University
Serving first 3-year term

Jeremy Rassen

Jeremy Rassen, FISPE
Co-Founder, President and Chief Science Officer at Aetion, Inc.,
New York, NY
Serving first 3-year term

Montse Soriano Gabarro

Montse Soriano Gabarro, FISPE
Head of Epidemiology
Bayer AG
Berlin, Germany
Serving second 3-year term

Shirley Wang

Shirley Wang, FISPE
Assistant Professor, Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital
Harvard Medical School
Boston, USA
Serving first 3-year term

Class of 2024

Jennifer Lund

Jennifer Lund, FISPE
Associate Professor, Department of Epidemiology
University of North Carolina at Chapel Hill
Chapel Hill, USA
Serving first 3-year term

Stine Hasling Mogensen

Stine Hasling Mogensen
Senior Advisor
Danish Medicines Agency's Data Analytic Centre
Copenhagen, Denmark
Serving first 3-year term

Daniel Prieto-Alhambra

Daniel Prieto-Alhambra, FISPE
Professor of Pharmaco- and Device Epidemiology
Centre for Statistics in Medicine
Oxford, UK
Serving first 3-year term

Yoshiaki Uyama

Yoshiaki Uyama
Director, Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA)
Tokyo, Japan
Serving first 3-year term

Hongbo Yuan

Hongbo Yuan
Scientific Advisor, Evidence Standard
Canadian Agency for Drugs and Technologies in Health
Ottawa, Canada
Serving first 3-year term

Class of 2025

Gillian Caughey

Gillian Caughey
Associate Director/Adjunct A/Professor
Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, ‎South Australian Health and Medical Research Institute
Adelaide, Australia
Serving first 3-year term

Efe Eworuke

Efe Eworuke
Associate Director, Science
Office of Pharmacovigilance and Epidemiology
Office of Surveillance and Epidemiology
Center for Drug Evaluation and Research, US FDA
Silver Spring, Maryland, USA
Serving first 3-year term

Jessica Franklin

Jessica Franklin
Principal Consultant, Epidemiology and Real-World Evidence
Boston, Massachusetts, USA
Serving first 3-year term

Ursula Kirchmayer

Ursula Kirchmayer, FISPE
Department of Epidemiology, ASL Roma1,
Lazio Regional Health Service
Rome, Italy
Serving second 3-year term

ndrea Margulis

Andrea Margulis, FISPE‎
Director, Epidemiology RTI Health Solutions
RTI International
Barcelona, Spain
Serving first 3-year term

Lifetime Emeritus

Stanley A. Edlavitch

Stanley A. Edlavitch, FISPE
University of Missouri School of Medicine
Kansas City, USA

ISPE Strategic Liaisons

International Network for Epidemiology in Policy (INEP): Meredith Smith, FISPE; Susan dosReis, FISPE
Council for International Organizations of Medical Sciences (CIOMS): Stella Blackburn, FISPE
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP): K. Arnold Chan, FISPE
US Food and Drug Administration: Christian Hampp, FISPE